Department of Pediatric Cardiology, Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Bezirganbahce Street, Halkali, Istanbul, 34303, Turkey.
J Interv Card Electrophysiol. 2023 Dec;66(9):2153-2164. doi: 10.1007/s10840-023-01675-w. Epub 2023 Oct 21.
Intracoronary sinus ablations have been performed for various arrhythmical substrates. The aim of this study is to report our experience on pediatric patients of the safety and efficacy of ablations in the coronary sinus.
This is a retrospective study of all patients who underwent ablations in the coronary sinus from October 2013 to October 2021 at a single center. Clinical presentation, type of arrhythmia causing tachycardia, ablation procedure, and outcome were recorded.
A total of 27 patients were included in the study. Nineteen (69%) of those followed up received a diagnosis of Wolff-Parkinson-White syndrome (WPW), 4 (15%) were cases of supraventricular tachycardia with concealed accessory pathway (AP), 2 (8%) were cases of focal atrial tachycardia, and 2 (8%) were cases of permanent junctional reciprocating tachycardia. Negative delta wave was noteworthy especially in lead II in 11/19 (58%) cases and coronary sinus diverticulum was detected in the WPW cases. Of those with manifest AP (19 cases), 15 (79%) had a high-risk AP and the AP in all WPW cases was adenosine unresponsive. Radiofrequency (RF) catheter ablation was performed in 25/27 (93%) cases during the procedure, and 16/25 (64%) of these were irrigated RF catheters. No complications were observed in the follow-up, including coronary artery injury.
Catheter ablation of supraventricular tachyarrhythmias can be accomplished effectively and potentially safely within the coronary sinus. Coronary sinus diverticula should be suspected in patients with manifest posteroseptal APs who have a previous failed ablation and typical electrocardiographic signs.
已经针对各种心律失常基质进行了冠状窦内消融。本研究的目的是报告我们在单一中心对接受冠状窦消融的儿科患者的安全性和疗效经验。
这是一项回顾性研究,纳入了 2013 年 10 月至 2021 年 10 月期间在单一中心接受冠状窦消融的所有患者。记录临床特征、引起心动过速的心律失常类型、消融程序和结果。
共纳入 27 例患者。其中 19 例(69%)经随访诊断为预激综合征(WPW),4 例(15%)为隐匿性旁路参与的房室结折返性心动过速(AVNRT),2 例(8%)为局灶性房性心动过速,2 例(8%)为永久性交接区折返性心动过速。在 19 例 WPW 患者中,有 11 例(58%)的 delta 波在 II 导联中明显,且均发现冠状窦憩室。在表现为显性旁路的 19 例患者中,有 15 例(79%)为高危旁路,所有 WPW 患者的旁路均对腺苷无反应。在 27 例患者中,25 例(93%)在手术过程中进行了射频(RF)导管消融,其中 16 例(64%)使用了灌流 RF 导管。在随访中未观察到并发症,包括冠状动脉损伤。
冠状窦内消融治疗室上性心动过速是有效且潜在安全的。对于既往消融失败且具有典型心电图特征的显性后间隔旁路患者,应怀疑存在冠状窦憩室。